Difficulty: Medium
Average Score: 84%
Practice
Which of the following drugs is used to treat bacterial infections by inhibiting bacterial protein synthesis?
Correct answer
B
Rationale
In the context of pharmacological lifespan treatment, it is crucial to understand the mechanisms of action of different drugs to ensure effective treatment. In this case, the correct answer is B) Erythromycin. Erythromycin is a macrolide antibiotic that works by inhibiting bacterial protein synthesis. It binds to the 50S subunit of the bacterial ribosome, preventing the elongation of the peptide chain during protein synthesis, ultimately leading to bacterial cell death.
Option A) Amoxicillin is a beta-lactam antibiotic that works by disrupting the bacterial cell wall synthesis, not by inhibiting protein synthesis. It is effective against a different range of bacteria compared to erythromycin.
Option C) Ciprofloxacin is a fluoroquinolone antibiotic that works by inhibiting bacterial DNA gyrase and topoisomerase IV, which are enzymes involved in DNA replication and repair. It does not target bacterial protein synthesis like erythromycin.
Option D) Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. However, erythromycin is a more common choice for inhibiting bacterial protein synthesis compared to clindamycin.
Understanding the specific mechanisms of action of antibiotics is essential for healthcare professionals to make informed decisions when treating bacterial infections and to prevent the development of antibiotic resistance. In this case, selecting erythromycin as the correct answer demonstrates knowledge of its role in inhibiting bacterial protein synthesis, a key aspect of its pharmacological action.
Option A) Amoxicillin is a beta-lactam antibiotic that works by disrupting the bacterial cell wall synthesis, not by inhibiting protein synthesis. It is effective against a different range of bacteria compared to erythromycin.
Option C) Ciprofloxacin is a fluoroquinolone antibiotic that works by inhibiting bacterial DNA gyrase and topoisomerase IV, which are enzymes involved in DNA replication and repair. It does not target bacterial protein synthesis like erythromycin.
Option D) Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. However, erythromycin is a more common choice for inhibiting bacterial protein synthesis compared to clindamycin.
Understanding the specific mechanisms of action of antibiotics is essential for healthcare professionals to make informed decisions when treating bacterial infections and to prevent the development of antibiotic resistance. In this case, selecting erythromycin as the correct answer demonstrates knowledge of its role in inhibiting bacterial protein synthesis, a key aspect of its pharmacological action.